a unicenter , single-blind , randomized study was conducted on 283 patients with active duodenal ulcer to compare possible factors that may affect healing and relapse in patients treated with a potent antisecretory agent , cimetidine , or a site-protective and cytoprotective agent , sucralfate .
C0013295
duodenal ulcer
C0038633
sucralfate